Do you have a clear and specific interest in cancer, stem cells or developmental biology? Our Master’s programme Cancer, Stem Cells and Developmental Biology combines research in three areas: oncology, molecular developmental biology and genetics. The focus is on molecular and cellular aspects of development and disease, utilising different model systems (mice, zebrafish, C. elegans, organoids and cell lines). The programme will guide you through the mysteries of embryonic growth, stem cells, signalling, gene regulation, evolution, and development as they relate to health and disease.
Given that fundamental developmental processes are so often impacted by disease, an understanding of these processes is vital to the better understanding of disease treatment and prevention. Adult physiology is regulated by developmental genes and mechanisms which, if deregulated, may result in pathological conditions. If you have a specific interest in cancer, stem cells or developmental biology, this Master’s programme is the right choice for you. Cancer, Stem Cells and Developmental Biology offers you international, high ranked research training and education that builds on novel methodology in genomics, proteomics, metabolomics and bioinformatics technology applied to biomedical and developmental systems and processes.
In the Cancer, Stem Cells and Developmental Biology programme you will learn to focus on understanding processes underlying cancer and developmental biology using techniques and applications of post-genomic research, including microarray analysis, next generation sequencing, proteomics, metabolomics and advanced microscopy techniques. You explore research questions concerning embryonic growth, stem cells, signaling pathways, gene regulation, evolution and development in relation to health and disease using various model systems. As a Master’s student you will take theory courses and seminars, as well as master classes led by renowned specialists in the field. The courses are interactive, and challenge you to further improve your writing and presenting skills.
Compared to most other Master’s programmes in cancer and stem cell biology in the Netherlands, in Utrecht we offer:
As a MSc graduate trained in both fundamental and disease-oriented aspects of biomedical genetics you are in great demand. You’ll be prepared for PhD study in one of the participating or associated groups. Alternatively, leaving after obtaining your MSc degree you will profit from a solid education in molecular genetics, in addition to your specialised knowledge of developmental biology. You’ll find your way to biotechnology, the pharmaceutical industry or education.
Regenerative Medicine and Technology (RMT) combines fundamental disciplines such as stem cell biology, materials science and biomechanics with more applied disciplines such as cell therapy, implantology and imaging. New collaborations amongst these disciplines can assist in innovation in fundamental life sciences but also in new patient therapies and clinical applications with the ultimate goal to restore lost tissue or organ function.
This Master’s programme aims to train multidisciplinary scientists and to stimulate innovative research at the interface between biomedical sciences, engineering and clinical application. The rapidly emerging multidisciplinary field of regenerative medicine has significant effects on current and future health care applications. Our strong focus on technology will equip you with an understanding of processes ranging from specific cell culturing techniques and the use of biomaterials to computer models and imaging modalities.
Utrecht University offers the Master’s programme in cooperation with the University Medical Center Utrecht and the Faculty of Biomedical Engineering at Eindhoven University of Technology (TU/e). The programme combines the expertise of both universities and provides access to their state-of-the-art laboratories and research groups.
As a Master’s student of Regenerative Medicine and Technology you will take theoretical courses and seminars as well as master classes led by renowned specialists in the field in both Eindhoven and Utrecht. The courses are interactive, and challenge students to further improve their communication, writing and presenting skills. During your six to nine month internships you work in a lively research environment in academia or in consultancy companies and industry.
Regenerative Medicine and Technology will address the shortage of donor organs/tissue by providing the opportunity to produce tissue substitutes. As a graduates you can pursue a career in academic (PhD) or in industrial and commercial directions, including R&D, sales and consultancy.
This Master's degree in Cell and Gene Therapy provides an in-depth education in this cutting-edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques.
The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and complete a practical laboratory-based project.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits) and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months or flexible up to five years) is offered
A Postgraduate Certificate (60 credits, full-time 12 weeks, part-time nine months, or up to two years flexible) is offered.
Research Methodology and Statistics is not a core module for the PG Certificate. Students of the PG Certificate can choose an optional module.
All MSc students undertake an independent research project which culminates in a dissertation.
Teaching and learning
Teaching includes lectures, seminars, problem classes and tutorials. Assessment varies depending on the module, but includes written coursework, multiple-choice questions, written examinations, a practical analysis examination and the dissertation of up to 10,000 words
Further information on modules and degree structure is available on the department website: Cell and Gene Therapy MSc
This programme aims to equip students for careers in research, education, medicine and business in academic, clinical and industrial settings. Examples of potential careers could include academic research and/or lecturing in a university or other higher education setting, conducting clinical trials as part of a team of clinicians, scientists and allied health professionals, monitoring and analysing the results of clinical trials as part of a clinical trials unit, developing new therapies or intellectual property in the pharmaceutical industry or other business ventures.
Several of our graduates have gone on to secure PhD places. You can read testimonials from past students which include their destinations following graduation.
Recent career destinations for this degree
Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.
The UCL Great Ormond Street Institute of Child Health (UCL GOS ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical, basic research and postgraduate education in children's health, including haematopoietic stem cell transplantation (HSCT) and gene therapy.
The UCL School of Life & Medical Sciences (SLMS) has the largest concentration of clinicians and researchers active in cell and gene therapy research in Europe. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers at UCL GOS ICH, the Division of Infection & Immunity, the Institute of Ophthalmology, the Institute for Women's Health, the Institute of Genetics and the Cancer Institute.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Great Ormond Street Institute of Child Health
80%: Clinical Medicine subjects; 81%: Public Health, Health Services and Primary Care subjects rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
The only Master’s specialisation in the Netherlands covering the function of our epigenome, a key factor in regulating gene expression and in a wide range of diseases.
Our skin cells, liver cells and blood cells all contain the same genetic information. Yet these are different types of cells, each performing their own specific tasks. How is this possible? The explanation lies in the epigenome: a heritable, cell-type specific set of chromosomal modifications, which regulates gene expression. Radboud University is specialised in studying the epigenome and is the only university in the Netherlands to offer a Master’s programme in this field of research.
The epigenome consists of small and reversible chemical modifications of the DNA or histone proteins, such as methylation, acetylation and phosphorylation. It changes the spatial structure of DNA, resulting in gene activation or repression. These processes are crucial for our health and also play a role in many diseases, like autoimmune diseases, cancer and neurological disorders. As opposed to modifications of the genome sequence itself, epigenetic modifications are reversible. You can therefore imagine the great potential of drugs that target epigenetic enzymes, so-called epi-drugs.
In this specialisation, you’ll look at a cell as one big and complex system. You’ll study epigenetic mechanisms during development and disease from different angles. This includes studying DNA and RNA by next-generation sequencing (epigenomics) and analysing proteins by mass spectrometry (proteomics). In addition, you‘ll be trained to design computational strategies that allow the integration of these multifaceted, high-throughput data sets into one system.
- Radboud University combines various state-of-the-art technologies – such as quantitative mass spectrometry and next-generation DNA sequencing – with downstream bioinformatics analyses in one department. This is unique in Europe.
- This programme allows you to work with researchers from the Radboud Institute for Molecular Life sciences (RIMLS), one of the leading multidisciplinary research institutes within this field of study worldwide.
- We have close contacts with high-profile medically oriented groups on the Radboud campus and with international institutes (EMBL, Max-Planck, Marie Curie, Cambridge, US-based labs, etc). As a Master’s student, you can choose to perform an internship in one of these related departments.
- Radboud University coordinates BLUEPRINT, a 30 million Euro European project focusing on the epigenomics of leukaemia. Master’s students have the opportunity to participate in this project.
As a Master’s student of Medical Epigenomics you’re trained in using state-of-the art technology in combination with biological software tools to study complete networks in cells in an unbiased manner. For example, you’ll know how to study the effects of drugs in the human body.
When you enter the job market, you’ll have:
- A thorough background of epigenetic mechanisms in health and disease, which is highly relevant in strongly rising field of epi-drug development
- Extensive and partly hands-on experience in state-of-the-art ‘omics’ technologies: next-generation sequencing, quantitative mass spectrometry and single cell technologies;
- Extensive expertise in designing, executing and interpreting scientific experiments in data-driven research;
- The computational skills needed to analyse large ‘omics’ datasets.
With this background, you can become a researcher at a:
- University or research institute;
- Pharmaceutical company, such as Synthon or Johnson & Johnson;
- Food company, like Danone or Unilever;
- Start-up company making use of -omics technology.
Apart from research into genomics and epigenomics, you could also work on topics such as miniaturising workflows, improving experimental devices, the interface between biology and informatics, medicine from a systems approach.
Or you can become a:
- Biological or medical consultant;
- Biology teacher;
- Policy coordinator, regarding genetic or medical issues;
- Patent attorney;
- Clinical research associate;
Each year, the Molecular Biology department (Prof. Henk Stunnenberg, Prof. Michiel Vermeulen) and the Molecular Developmental Biology department (Prof. Gert-Jan Veenstra) at the RIMLS offer between five and ten PhD positions. Of course, many graduates also apply for a PhD position at related departments in the Netherlands, or abroad.
- Systems biology
In the Medical Epigenomics specialisation you won’t zoom in on only one particular gene, protein or signalling pathway. Instead, you’ll regard the cell as one complete system. This comprehensive view allows you to, for example, model the impact of one particular epigenetic mutation on various parts and functions of the cell, or study the effects of a drug in an unbiased manner. One of the challenges of this systems biology approach is the processing and integration of large amounts of data. That’s why you’ll also be trained in computational biology. Once graduated, this will be a great advantage: you’ll be able to bridge the gap between biology, technology and informatics , and thus have a profile that is desperately needed in modern, data-driven biology.
- Multiple OMICS approaches
Studying cells in a systems biology approach means connecting processes at the level of the genome (genomics), epigenome (epigenomics), transcriptome (transcriptomics), proteome (proteomics), etc. In the Medical Epigenomics specialisation, you’ll get acquainted with all these different fields of study.
- Patient and animal samples
Numerous genetic diseases are not caused by genetic mutations, but by epigenetic mutations that influence the structure and function of chromatin. Think of:
- Autoimmune diseases, like rheumatoid arthritis and lupus
- Cancer, in the forms of leukaemia, colon cancer, prostate cancer and cervical cancer
- Neurological disorders, like Rett Syndrome, Alzheimer, Parkinson, Multiple Sclerosis, schizophrenia and autism
We investigate these diseases on a cellular level, focusing on the epigenetic mutations and the impact on various pathways in the cell. You’ll get the chance to participate in that research, and work with embryonic stem cell, patient, Xenopus or zebra fish samples.
See the website http://www.ru.nl/masters/medicalbiology/epigenomics
Training in biotechnology research with a strong emphasis on development of advanced practical skills and research methods.
MSc Biotechnology Research is designed to provide up-to-date knowledge and understanding of core areas of biotechnology with particular emphasis on enhancing practical and research skills. Within the programme, students will cover a range of diverse topics including: bioinformatics, diagnostics, genetic modification, stem cell technology and proteomics and modules will include "hands on" training in advanced laboratory techniques. Further study in research planning, scientific communication, and professional practice will provide opportunities for critical reflection and evaluation of current practice and policy, enabling lifelong learning and professional development in biotechnology.
The course has a strong practical element, with laboratory classes integrated in the modules across the first two semesters. Over the summer semester students also have the opportunity to undertake their own independent research project within one of the research groups in the internationally renowned Biomedical Sciences Research Institute (BMSRI) at Ulster. The BMSRI research covers biomedicine from the molecular to the whole human including disease development, prevention, diagnosis and therapy. BMSRI is ranked within the top five out of 94 universities submitted in the UK REF2014 panel in terms of research power in biomedical science. Significantly, in REF2014 our research environment was awarded an unprecedented 100% 4* (world-leading) and 95% of our research impact was scored world leading (4*) and internationally excellent (3*) while 81% of research published papers were judged to be world leading and internationally excellent (4* and 3*).
The course is primarily designed for those who wish to develop their career in the biosciences with particular emphasis on biotechnology research; including either academia or bio-pharmaceutical and bio-industries.
On completion of this course, students will have gained experience of advanced laboratory techniques, problem-solving and research design in a range of Biotechnology areas and be well prepared to work in research positions or to proceed on to do a research degree in a related area.
How to apply: https://www.ulster.ac.uk/apply/how-to-apply#pg
1. Over 92% of our graduates are in work or further study six months after graduation.
2. We are a top UK university for providing courses with a period of work placement.
3. Our teaching and the learning experience we deliver are rated at the highest level by the Quality Assurance Agency.
4. We recruit international students from more than 100 different countries.
5. More than 4,000 students from over 50 countries have successfully completed eLearning courses at Ulster University.
To help spread the cost of your studies, tuition fees can be paid back in monthly instalments while you learn. If you study for a one-year, full-time master’s, you can pay your fees up-front, in one lump sum, or in either five* or ten* equal monthly payments. If you study for a master’s on a part-time basis (e.g. over three years), you can pay each year’s fees up-front or in five or ten equal monthly payments each year. This flexibility allows you to spread the payment of your fees over each academic year. Find out more by visiting https://www.ulster.ac.uk/apply/fees-and-finance/postgraduate
A comprehensive range of financial scholarships, awards and prizes are available to undergraduate, postgraduate and research students. Scholarships recognise the many ways in which our students are outstanding in their subject. Individuals may be able to apply directly or may automatically be nominated for awards. Visit the website: https://www.ulster.ac.uk/apply/fees-and-finance/scholarships
CELT offers courses and consultations in English language and study skills to Ulster University students of all subjects, levels and nationalities. Students and researchers for whom English is an additional language can access free CELT support throughout the academic year: https://www.ulster.ac.uk/international/english-language-support
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
If you have ever spent some time in hospital, you are probably unaware that you were the beneficiary of medical devices that have been designed and developed by Medical Engineering Designers. Everything from the bed you lie on to the MRI scanner that shows your insides on a screen, to the blood pressure monitor, to the scalpel that cuts your skin is known as a Medical Device and will have had input from Medical Engineering Designers. Even if you have a blood pressure monitor at home, this is still a medical device and will have been designed by a Medical Engineering Designer. The aim of the MSc in Medical Engineering Design is to convert you into a Medical Engineering Designer so that you can work in this highly regulated design discipline.
Teaching takes place at the Guy Hilton Research Centre, a dedicated research facility located on the Royal Stoke University Hospital site, and also at the main University Campus. The School of Medicine is one of the top-ranked in the UK, and the research institute has an international reputation for world-leading research (https://www.keele.ac.uk/istm/newsandevents/istmnews2015/istmrefratingsmar2014.php) in medical engineering and healthcare technologies.
The Guy Hilton Research Centre offers state-of-the-art laboratories housing equipment for translational research including newly-developed diagnostic instruments, advanced imaging modalities and additive manufacturing facilities. Its location adjacent to the University Hospital ensures that students experience real-world patient care and the role that technology plays. Students also have access to advanced equipment for physiological measurement, motion analysis and functional assessment in other hospital and campus-based laboratories.
The School embraces specialists working in Royal Stoke University Hospital, County Hospital in Stafford and specialist Robert Jones and Agnes Hunt Orthopaedic Hospital in Oswestry. You therefore have the opportunity to specialise in any of the varied clinical disciplines offered at these hospitals.
Download the MSc Medical Engineering Design Leaflet (https://www.keele.ac.uk/media/keeleuniversity/fachealth/fachealthmed/postgraduate/MSc%20in%20Medical%20Engineering%20Design%20web.pdf)
The School also runs MSc courses in Biomedical Engineering (https://www.keele.ac.uk/pgtcourses/biomed/) and in Cell and Tissue Engineering (https://www.keele.ac.uk/pgtcourses/biomed/), and an EPSRC and MRC-funded Centre for Doctoral Training, ensuring a stimulating academic environment for students and many opportunities for engaging with further study and research.
As a postgraduate student at Keele not only will you be joining a vibrant undergraduate community you will also be part of Keele's celebrated postgraduate family (the first student union dedicated to postgraduate students in the country). For more information on postgraduate life at Keele follow this link to the Keele Postgraduate Association (the link is http://www.kpa.org.uk).
Between March and September 2017 the University will be holding a number of Postgraduate Open Afternoons (https://www.keele.ac.uk/visiting/postgraduateopenafternoons/) to give prospective students the opportunity to visit the campus and learn more about Keele and postgraduate life in general. Please visit the Postgraduate Open Afternoons web page for more information.
Because this is a “conversion” course you need not have an engineering degree to apply. You must have a STEM (Science, Technology, Engineering or Mathematics) based degree, but that could be anything from Biomedical Science, through Forensic Science, to Computer Science. Of course, if you have an engineering degree you can still apply.
We welcome applications with a first or second-class degree (or equivalent) in a STEM (Science, Technology, Engineering or Mathematics) discipline. We also welcome enquiries from people with other professional qualifications acceptable to the University.
We recommend applicants discuss their first degree with the course tutor before applying to ensure that this course meets personal aspirations.
For international applicants, an English language IELTS score of 6.5 is required.
Whether you are a new graduate or already employed and seeking to further your career prospects, this course offers a solid career development path. You can also choose this course if you wish to pursue research in biotechnology at PhD level.
Biotechnology is the application of biological processes and is underpinned by • cell biology • molecular biology • bioinformatics • structural biology. It encompasses a wide range of technologies for modifying living organisms or their products according to human needs.
Applications of biotechnology span medicine, technology and engineering.
Important biotechnological advances including
The course is led by academics who are actively involved in biotechnology research and its application to the manipulation of proteins, DNA, mammalian cells and plants. Staff also have expertise in the use of nanoparticles in drug delivery and the manipulation of microbes in industrial and environmental biotechnology.
You are supported throughout your studies by an academic advisor who will help you develop your study and personal skills.
What is biotechnology
Biotechnology is the basis for the production of current leading biopharmaceuticals and has already provided us with the 'clot-busting' drug, tissue plasminogen activator for the treatment of thrombosis and myocardial infarction. It also holds the promise of new treatments for neurodegeneration and cancer through recombinant antibodies.
Genetically modified plants have improved crop yields and are able to grow in a changing environment. Manipulation of cellular organisms through gene editing methods have also yielded a greater understanding of many disease states and have allowed us to understand how life itself functions.
You begin your studies focusing on the fundamentals of advanced cell biology and molecular biology before specialising in both molecular and plant biotechnology. Practical skills are developed throughout the course and you gain experience in molecular biology techniques such as PCR and sub cloning alongside tissue culture.
Core to the program is the practical module where you gain experience in a range of techniques used in the determination of transcription and translational levels, for example.
All practicals are supported by experienced academic staff, skilled in the latest biotechnological techniques.
Research and statistical skills are developed throughout the program. Towards the end of the program you apply your skills on a two month research project into a current biotechnological application. Employability skills are developed throughout the course in two modules.
The masters (MSc) award is achieved by successfully completing 180 credits.
The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.
The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.
Optional modules :
As students progress through the course they are exposed to a wide range of teaching and learning activities. The assessment strategy of the postgraduate course considers diverse assessment methods. Some modules offer dedicated formative feedback to aid skills development with assessments going through several rounds of formative tutor and peer feedback. Summative assessment methods are diverse, with examinations present in theory-based modules to test independent knowledge and data analysis. Several modules are entirely coursework-based, with a portfolio of skills such laboratory practical's and research proposals generated throughout the course forming the summative tasks. In all cases, the assessment criteria for all assessed assignments are made available to student prior to submission.
The course is suitable for people wishing to develop their knowledge of molecular and cell biotechnology and its application to solving health and industrial problems.
You can find career opportunities in areas such as
Students on this course have gone on to roles including experimental officers in contract research, research and development in scientists, diagnostics specialists and applications specialists. Many of our graduates also go on to study for PhDs and continue as academic lecturers.